Literature DB >> 9798033

Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients.

W C Ko1, Y C Chuang, G C Huang, S Y Hsu.   

Abstract

Although Taiwan is not an area where cholera is endemic, from October 1988 to October 1997 30 episodes of non-O1, non-O139 Vibrio cholerae infection were noted at the National Cheng Kung University Hospital in Taiwan. Infections generally occurred in hot seasons, and two episodes were concomitant with Vibrio vulnificus infection. Three major clinical presentations were found: bacteremia with concurrent spontaneous bacterial peritonitis or invasive soft-tissue infections that occurred solely in cirrhotic patients; self-limited acute febrile gastroenteritis that occurred in patients with no underlying medical disease; and necrotizing fasciitis or cellulitis that often resulted from a wound on extremities. Other manifestations included fatal pneumonitis in a drowned man and acute pyosalpinx. The differential diagnosis of invasive infections in cirrhotic patients should include infections due to non-O1 V. cholerae or V. vulnificus, and a third-generation cephalosporin and a tetracycline analogue or a fluoroquinolone alone is recommended for treatment of severe vibrio infections.

Entities:  

Mesh:

Year:  1998        PMID: 9798033     DOI: 10.1086/514947

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

1.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

2.  Vibrio fluvialis peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.

Authors:  Natasha Ratnaraja; Timothy Blackmore; Joan Byrne; Shuning Shi
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.

Authors:  W-L Liu; Y-H Chiu; C-M Chao; C-C Hou; C-C Lai
Journal:  Infection       Date:  2011-06-28       Impact factor: 3.553

4.  Population Structure and Multidrug Resistance of Non-O1/Non-O139 Vibrio cholerae in Freshwater Rivers in Zhejiang, China.

Authors:  Yun Luo; Henghui Wang; Jie Liang; Huiqin Qian; Julian Ye; Lixia Chen; Xianqing Yang; Zhongwen Chen; Fei Wang; Sophie Octavia; Michael Payne; Xiaojun Song; Jianmin Jiang; Dazhi Jin; Ruiting Lan
Journal:  Microb Ecol       Date:  2021-01-07       Impact factor: 4.552

5.  Vibrio cholerae non-O1,non-O139 isolated from pleural effusion following total gastrectomy.

Authors:  Jung-Ho Suk; Nam Yong Lee; Jang Ho Lee; Won Sup Oh; Kyoung Ran Peck; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

6.  The Role of Vibrio cholerae Haemagglutinin Protease (HAP) in Extra-Intestinal Infection.

Authors:  Amit Ghosh; Hemanta Koley; Amit Pal
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 7.  The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists.

Authors:  Ponni V Perumalswami; Thomas D Schiano
Journal:  Dig Dis Sci       Date:  2011-03-18       Impact factor: 3.199

8.  Clinical manifestation and prognostic factors of non-cholerae Vibrio infections.

Authors:  C C Hou; C C Lai; W L Liu; C M Chao; Y H Chiu; P R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-22       Impact factor: 3.267

9.  Vibrio cholerae non-O1, non-O139 bacteraemia associated with pneumonia, Italy 2016.

Authors:  Serena Marinello; Giulia Marini; Giancarlo Parisi; Lorena Gottardello; Lucia Rossi; Valeria Besutti; Anna Maria Cattelan
Journal:  Infection       Date:  2016-11-11       Impact factor: 3.553

10.  Characterization of novel alleles of toxin co-regulated pilus A gene (tcpA) from environmental isolates of Vibrio cholerae.

Authors:  Praveen Kumar; Anuja Thulaseedharan; Gautam Chowdhury; Thandavarayan Ramamurthy; Sabu Thomas
Journal:  Curr Microbiol       Date:  2010-10-22       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.